Larson Financial Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$77.7K Buy
404
+302
+296% +$49.1K ﹤0.01% 1374
2026
Q2
$13.9K Buy
102
+83
+437% +$10.2K ﹤0.01% 2210
2026
Q1
$2.24K Buy
+19
New +$2.65K ﹤0.01% 2923
2025
Q3
– Sell
-2
Closed -$249 – 3609
2025
Q2
$249 Sell
2
-59
-97% -$7.51K ﹤0.01% 3024
2025
Q1
$7.76K Buy
61
+60
+6,000% +$9.24K ﹤0.01% 1727
2024
Q4
$144 Hold
1
– – ﹤0.01% 2535
2024
Q3
$149 Buy
+1
New +$143 ﹤0.01% 2456

Other funds holding RGEN

Larson Financial Group's RGEN Position: Q3 2026 in Review

Larson Financial Group increased its Repligen (RGEN) stake by 296% in Q3 2026, buying an estimated $49.1K and bringing the position to 404 shares worth $77.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1374.

Larson Financial Group first reported a position in RGEN in Q3 2024 and has held it in 7 quarters since. 403 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Larson Financial Group held 404 shares of Repligen worth $77.7K as of Q3 2026.
  • Larson Financial Group bought 302 Repligen shares in Q3 2026, an estimated $49.1K.
  • Repligen made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #1374 holding.
  • Larson Financial Group first reported a position in Repligen in Q3 2024 and has held it in 7 quarters since.
  • 403 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.